Holostem Competitors and Similar CompaniesClear all
Holostem's competitors and similar companies include Polyplus-transfection, VCANBIO, Acorda Therapeutics and Right To Care.
 Holostem Holostem Terapie Avanzate is a biotech company devoted to the development of Advanced Therapies Medicinal Products (ATMPs) based on cultures of epithelial stem cells. |  Polyplus-transfection Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics. |  VCANBIO VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products. |  Acorda Therapeutics Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. |  Right To Care Right To Care is a non-profit organization that supports and delivers prevention, care, and treatment for HIV and associated diseases in South Africa. | |
Founding Date | Founding Date 2008 | Founding Date 2002 | Founding Date 1993 | Founding Date 1995 | Founding Date 2001 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Modena, IT HQ | Locations Illkirch-Graffenstaden, FR HQ New York, US | Locations Tianjin, CN HQ | Locations Ardsley, US HQ Chelsea, US South San Francisco, US Waltham, US | |
Employees | Employees 58 | Employees 1133% increase | Employees 2,0149% decrease | Employees 4742% decrease | Employees 1,817 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.4 b | Valuation ($) 821 k | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥1.4b (FY, 2025) | Revenue (est.) $117.6m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥438.8m (FY, 2025) | Cost of goods $15.3m (FY, 2023) | Cost of goods N/A |
Net income | Net income N/A | Net income N/A | Net income ¥103.5m (FY, 2025) | Net income ($252.9m) (FY, 2023) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Polyplus-transfection
HQ
Illkirch-Graffenstaden, FR
Employees
113↑ 3% increase
Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics.
View companyVCANBIO
HQ
Tianjin, CN
Employees
2,014↓ 9% decrease
VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products.
View companyAcorda Therapeutics
HQ
Ardsley, US
Employees
474↓ 2% decrease
Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.
View companyRight To Care
HQ
Centurion, ZA
Employees
1,817
Right To Care is a non-profit organization that supports and delivers prevention, care, and treatment for HIV and associated diseases in South Africa.
View company